Drivers of disparities in stage at diagnosis among women with breast cancer: South African breast cancers and HIV outcomes cohort.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2023
Historique:
accepted: 05 02 2023
received: 04 08 2022
entrez: 16 2 2023
medline: 25 2 2023
pubmed: 17 2 2023
Statut: epublish

Résumé

In low- and middle-income countries (LMICs), advanced-stage diagnosis of breast cancer (BC) is common, and this contributes to poor survival. Understanding the determinants of the stage at diagnosis will aid in designing interventions to downstage disease and improve survival from BC in LMICs. Within the South African Breast Cancers and HIV Outcomes (SABCHO) cohort, we examined factors affecting the stage at diagnosis of histologically confirmed invasive breast cancer at five tertiary hospitals in South Africa (SA). The stage was assessed clinically. To examine the associations of the modifiable health system, socio-economic/household and non-modifiable individual factors, hierarchical multivariable logistic regression with odds of late-stage at diagnosis (stage III-IV), was used. The majority (59%) of the included 3497 women were diagnosed with late-stage BC disease. The effect of health system-level factors on late-stage BC diagnosis was consistent and significant even when adjusted for both socio-economic- and individual-level factors. Women diagnosed in a tertiary hospital that predominantly serves a rural population were 3 times (OR = 2.89 (95% CI: 1.40-5.97) as likely to be associated with late-stage BC diagnosis when compared to those diagnosed at a hospital that predominantly serves an urban population. Taking more than 3 months from identifying the BC problem to the first health system entry (OR = 1.66 (95% CI: 1.38-2.00)), and having luminal B (OR = 1.49 (95% CI: 1.19-1.87)) or HER2-enriched (OR = 1.64 (95% CI: 1.16-2.32)) molecular subtype as compared to luminal A, were associated with a late-stage diagnosis. Whilst having a higher socio-economic level (a wealth index of 5) reduced the probability of late-stage BC at diagnosis, (OR = 0.64 (95% CI: 0.47-0.85)). Advanced-stage diagnosis of BC among women in SA who access health services through the public health system was associated with both modifiable health system-level factors and non-modifiable individual-level factors. These may be considered as elements in interventions to reduce the time to diagnosis of breast cancer in women.

Identifiants

pubmed: 36795733
doi: 10.1371/journal.pone.0281916
pii: PONE-D-22-21910
pmc: PMC9934316
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0281916

Subventions

Organisme : NCI NIH HHS
ID : R01 CA192627
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA244559
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA250012
Pays : United States

Informations de copyright

Copyright: © 2023 Mapanga et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Breast Cancer Res Treat. 2017 Feb;162(1):105-114
pubmed: 28025716
Lancet Oncol. 2013 Apr;14(4):363-70
pubmed: 23375833
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Cancer Epidemiol Biomarkers Prev. 2016 Apr;25(4):613-23
pubmed: 26819266
Mol Clin Oncol. 2015 Jul;3(4):785-788
pubmed: 26171180
Asian Pac J Cancer Prev. 2021 Apr 01;22(4):1007-1017
pubmed: 33906291
BMC Public Health. 2013 Oct 09;13:947
pubmed: 24107190
Lancet. 2018 Mar 17;391(10125):1023-1075
pubmed: 29395269
Lancet Glob Health. 2020 Sep;8(9):e1203-e1212
pubmed: 32827482
Lancet Glob Health. 2016 Dec;4(12):e923-e935
pubmed: 27855871
World J Surg Oncol. 2018 Mar 22;16(1):63
pubmed: 29566711
N Engl J Med. 2014 Oct 2;371(14):1344-53
pubmed: 25265493
Breast. 2018 Feb;37:163-169
pubmed: 29246526
BMJ Open. 2016 Jan 04;6(1):e009905
pubmed: 26729392
J Glob Oncol. 2017 Apr;3(2):114-124
pubmed: 28706996
PLoS One. 2018 Feb 2;13(2):e0192071
pubmed: 29394271
PLoS One. 2019 Mar 20;14(3):e0212806
pubmed: 30893313
J Clin Oncol. 2005 Sep 20;23(27):6639-46
pubmed: 16170171
BMJ. 2021 Feb 24;372:n256
pubmed: 33627312
PLoS Med. 2014 Sep 09;11(9):e1001720
pubmed: 25202974
Int J Cancer. 2020 Jul 15;147(2):361-374
pubmed: 31600408
J Glob Oncol. 2019 Jul;5:1-10
pubmed: 31322993
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
BMC Public Health. 2020 Mar 4;20(1):289
pubmed: 32131787
Int J Cancer. 2018 Apr 15;142(8):1568-1579
pubmed: 29197068
Cancer Causes Control. 2017 Jul;28(7):685-697
pubmed: 28447308

Auteurs

Witness Mapanga (W)

Strengthening Oncology Services Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Department of Paediatrics, SAMRC/Wits Developmental Pathways to Health Research Unit, Faculty of the Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Division of Medical Oncology, Department of Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Shane A Norris (SA)

Strengthening Oncology Services Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Department of Paediatrics, SAMRC/Wits Developmental Pathways to Health Research Unit, Faculty of the Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Global Health Research Institute, School of Health and Human Development, University of Southampton, Southampton, United Kingdom.

Ashleigh Craig (A)

Division of Medical Oncology, Department of Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Oluwatosin A Ayeni (OA)

Strengthening Oncology Services Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Global Health Research Institute, School of Health and Human Development, University of Southampton, Southampton, United Kingdom.
South Africa Medical Research Council Common Epithelial Cancers Research Centre, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Wenlong C Chen (WC)

Strengthening Oncology Services Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
National Cancer Registry, National Health Laboratory Service, Johannesburg, South Africa.
Sydney Brenner Institute for Molecular Bioscience, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Judith S Jacobson (JS)

Herbert Irving Comprehensive Cancer Center, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, United States of America.
Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, United States of America.

Alfred I Neugut (AI)

Herbert Irving Comprehensive Cancer Center, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, United States of America.
Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, United States of America.
Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, United States of America.

Paul Ruff (P)

Strengthening Oncology Services Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Division of Medical Oncology, Department of Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
South Africa Medical Research Council Common Epithelial Cancers Research Centre, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Herbert Cubasch (H)

Strengthening Oncology Services Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
South Africa Medical Research Council Common Epithelial Cancers Research Centre, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Department of Surgery, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Daniel S O'Neil (DS)

Sylvester Comprehensive Cancer Center and Department of Medicine, Miller School of Medicine, University of Miami, Miami, Florida, United States of America.

Ines Buccimazza (I)

Strengthening Oncology Services Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Department of Surgery, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Sharon Čačala (S)

Strengthening Oncology Services Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Department of Specialized Surgery, Inkosi Albert Luthuli Central Hospital, Durban and Ngwelezane Hospital, University of KwaZulu-Natal, Empangeni, KwaZulu-Natal, South Africa.

Laura W Stopforth (LW)

Strengthening Oncology Services Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Departments of Surgery and Radiation Oncology, Grey's Hospital, University of KwaZulu-Natal, Pietermaritzburg, KwaZulu-Natal, South Africa.

Hayley A Farrow (HA)

Departments of Surgery and Radiation Oncology, Grey's Hospital, University of KwaZulu-Natal, Pietermaritzburg, KwaZulu-Natal, South Africa.

Sarah Nietz (S)

Department of Surgery, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Charlotte Maxeke Surgical Breast Unit, Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa.

Boitumelo Phakathi (B)

Department of Surgery, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Charlotte Maxeke Surgical Breast Unit, Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa.

Tobias Chirwa (T)

School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Valerie A McCormack (VA)

Section of Environment and Radiation, International Agency for Research on Cancer, Lyon, France.

Maureen Joffe (M)

Strengthening Oncology Services Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
South Africa Medical Research Council Common Epithelial Cancers Research Centre, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH